EC has a substantial immunological cell invasion in the tumor immunological environment, with cancer-related fibroblasts, CD8+ T cells, CD4+ T cells, dendritic cells (DCs), regulatory T cells, tumor-linked macrophages, and monocytes among the lymphocytes. This evidence concerns the gene CD4 and neoplasm.